FITC Anti-Human IL-17A Antibody[BL168]

FITC Anti-Human IL-17A Antibody[BL168]

Introducing the FITC Anti-Human IL-17A Antibody [BL168], a cutting-edge product meticulously designed to revolutionize the field of immunology research. This antibody, developed with utmost precision and expertise, offers an unparalleled opportunity to explore the intricate mechanisms underlying human IL-17A signaling pathways.

The FITC Anti-Human IL-17A Antibody [BL168] is a highly specific and sensitive tool, meticulously engineered to detect and quantify the presence of human IL-17A with exceptional accuracy. Its unique formulation ensures minimal cross-reactivity, guaranteeing reliable and reproducible results in a wide range of experimental settings.

This antibody, conjugated with Fluorescein Isothiocyanate (FITC), enables effortless visualization and localization of human IL-17A within complex biological samples. The FITC label, renowned for its exceptional brightness and photostability, ensures optimal signal detection and longevity, facilitating comprehensive analysis and interpretation of experimental data.

The FITC Anti-Human IL-17A Antibody [BL168] exhibits exceptional affinity and specificity towards human IL-17A, making it an indispensable tool for researchers investigating the role of this cytokine in various physiological and pathological processes. Its high sensitivity allows for the detection of even low levels of IL-17A, enabling the exploration of subtle changes in its expression and secretion.

This antibody has been rigorously validated through a series of stringent quality control measures, ensuring its reliability and reproducibility. Its exceptional performance has been demonstrated in a multitude of applications, including flow cytometry, immunofluorescence, and immunohistochemistry, making it a versatile tool for a wide range of experimental approaches.

In summary, the FITC Anti-Human IL-17A Antibody [BL168] represents a breakthrough in immunology research, offering an unprecedented opportunity to unravel the complexities of human IL-17A signaling. With its exceptional specificity, sensitivity, and versatility, this antibody is poised to revolutionize the understanding of IL-17A biology and pave the way for groundbreaking discoveries in the field.